Back to top
more

Baxter International (BAX)

(Delayed Data from NYSE)

$33.73 USD

33.73
4,219,536

-0.18 (-0.53%)

Updated Jun 18, 2024 04:00 PM ET

After-Market: $33.80 +0.07 (0.21%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 250)

Industry: Medical - Products

Better trading starts here.

Balance Sheet

Research for BAX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Baxter International Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 3,194 1,718 2,951 3,730 3,335
Receivables 2,690 2,659 2,629 2,077 1,896
Notes Receivable 0 0 0 0 0
Inventories 2,824 2,718 2,453 1,916 1,653
Other Current Assets 892 916 839 688 619
Total Current Assets 9,600 8,011 8,872 8,411 7,503
Net Property & Equipment 4,433 4,979 5,178 4,722 4,512
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 12,593 13,636 17,628 4,888 4,501
Deposits & Other Assets 1,126 1,111 1,213 1,395 1,069
Total Assets 28,276 28,287 33,521 20,019 18,193
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 1,241 1,139 1,246 2,927 2,689
Current Portion Long-Term Debt 2,668 1,404 511 406 541
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 2,594 2,202 2,479 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 6,503 4,745 4,236 3,333 3,230
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 11,130 15,232 17,149 5,786 4,809
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,737 1,959 2,493 1,673 1,732
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 19,808 22,392 24,400 11,293 10,281
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 683 683 683 683 683
Capital Surplus 6,389 6,322 6,197 6,043 5,955
Retained Earnings 16,114 14,050 17,065 16,328 15,718
Other Equity -3,488 -3,771 -3,336 -3,277 -3,680
Treasury Stock 11,230 11,389 11,488 11,051 10,764
Total Shareholder's Equity 8,468 5,895 9,121 8,726 7,912
Total Liabilities & Shareholder's Equity 28,276 28,287 33,521 20,019 18,193
Total Common Equity 8,468 5,895 9,121 8,726 7,912
Shares Outstanding 507.30 504.10 500.60 505.10 510.50
Book Value Per Share 16.69 11.69 18.22 17.28 15.50

Fiscal Year End for Baxter International Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 3,026 3,194 5,788 1,722 1,673
Receivables 2,521 2,690 2,512 2,495 2,547
Notes Receivable 0 0 0 0 0
Inventories 2,988 2,824 2,873 2,897 2,922
Other Current Assets 865 892 861 1,091 957
Total Current Assets 9,400 9,600 12,034 8,205 8,099
Net Property & Equipment 4,370 4,433 4,278 4,494 5,000
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 698 0
Deferred Charges 0 0 0 0 0
Intangibles 12,335 12,593 12,637 12,888 13,508
Deposits & Other Assets 1,152 1,126 1,188 1,067 1,130
Total Assets 27,788 28,276 30,656 27,885 28,291
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 1,329 1,241 1,246 1,240 1,290
Current Portion Long-Term Debt 2,634 2,668 2,426 2,177 1,153
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 2,402 2,594 2,537 2,278 2,317
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 70 0
Total Current Liabilities 6,365 6,503 6,209 5,765 4,760
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 11,092 11,130 14,067 14,306 15,278
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,652 1,778 1,745 1,854
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 19,553 19,808 22,490 22,254 22,350
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 683 683 683 683 683
Capital Surplus 6,339 6,389 6,368 6,341 6,312
Retained Earnings 16,003 16,114 16,015 13,655 13,947
Other Equity -3,660 -3,488 -3,651 -3,752 -3,677
Treasury Stock 11,130 11,230 11,249 11,296 11,324
Total Shareholder's Equity 8,235 8,468 8,166 5,631 5,941
Total Liabilities & Shareholder's Equity 27,788 28,276 30,656 27,885 28,291
Total Common Equity 8,235 8,468 8,166 5,631 5,941
Shares Outstanding 509.50 507.30 507.30 506.40 505.80
Book Value Per Share 16.16 16.69 16.10 11.12 11.75